Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
J Laryngol Otol ; 132(7): 651-656, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29893657

RESUMO

OBJECTIVES: To analyse publication and citations trends of case reports within otolaryngology - head and neck surgery literature, with specific attention to the most-cited reports.Study designDatabase query. METHODS: Web of Science was searched for article type 'case reports' published in the leading otolaryngology - head and neck surgery journals since 1945. Variables including publication dates, citation dates and numbers, author, author number, and others were recorded and analysed for trends. The reports with the most citations (classics) were further studied. RESULTS: Of nearly 67 000 published articles in leading otolaryngology - head and neck surgery journals, the overall number of case reports as a percentage of the total has substantially decreased over time. A total of 110 case report classics were identified for which citations have increased. CONCLUSION: Although the case report may not be worthy of its tarnished record, declining trends in publication suggest a limited future for this valuable research and educational resource.


Assuntos
Bibliometria , Prontuários Médicos , Otolaringologia/tendências , Procedimentos Cirúrgicos Otorrinolaringológicos , Humanos
2.
Cancer Lett ; 85(2): 223-32, 1994 Oct 14.
Artigo em Inglês | MEDLINE | ID: mdl-7954341

RESUMO

Factors controlling glutathione metabolism may govern sensitivity to chemotherapeutic agents such as cisplatin. Using a battery of cell lines derived from previously untreated head and neck squamous cell carcinomas, we examined cisplatin resistance relative to (a) glutathione-S-transferase (GST)-pi gene amplification and expression, (b) basal and inducible GST-total and GST-pi enzymatic activity, and (c) cellular levels of reduced glutathione (GSH). Using Southern blot analysis and northern blot hybridization, no relationship between GST-pi gene amplification, mRNA expression and drug resistance could be identified. Despite the capacity of cisplatin to induce GST enzyme activity, the response was variable and unrelated to cisplatin responsiveness. However, an inverse relationship between GSH levels and cisplatin sensitivity was identified. To further clarify these effects, cells were treated with S-allyl cysteine (SAC), a thioallyl derivative isolated from garlic (Allium sativum), which altered cellular GSH in a biphasic manner. Pretreatment with SAC to lower cellular GSH levels followed by exposure to cisplatin significantly enhanced the cytotoxic effects of cisplatin, while SAC alone had no effect on cell growth.


Assuntos
Carcinoma de Células Escamosas/metabolismo , Cisplatino/toxicidade , Glutationa Transferase/metabolismo , Glutationa/metabolismo , Neoplasias de Cabeça e Pescoço/fisiopatologia , Carcinoma de Células Escamosas/genética , Sobrevivência Celular/efeitos dos fármacos , Cromossomos Humanos Par 11 , Cisteína/administração & dosagem , Cisteína/análogos & derivados , Amplificação de Genes , Regulação Neoplásica da Expressão Gênica , Glutationa Transferase/genética , Humanos , Técnicas In Vitro , RNA Mensageiro/genética , Células Tumorais Cultivadas
3.
Surgery ; 99(6): 744-51, 1986 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-3520916

RESUMO

Activated complement, thromboxane A2, prostacyclin, and activated granulocytes have been implicated in hemodynamic dysfunction after trauma, in sepsis, and in hypovolemic and septic shock. This study evaluated the interaction of plasma concentrations of complement components C3a and C5a, thromboxane B2 (TxB), prostaglandin 6-keto-F1 alpha (PGI), and granulocyte aggregation in clinical sepsis and hypotension. Forty-eight critically ill patients were followed clinically for as long as 10 days. Plasma C3a, C5a, TxB, and PGI were measured daily by the radioimmunoassay method. Granulocyte aggregation, the percentage of maximum aggregation of zymosan-activated plasma standard curves, was performed with patient plasma and normal human leukocytes. Patients were studied in four groups: group I, nonseptic, normotensive; group II, hypovolemic shock, group III, normotensive severe sepsis; and group IV, septic shock. Plasma from 12 normal adults was the control value. PGI, TxB, C3a, C5a, and granulocyte aggregation in patients were greater than that in the control subjects. Granulocyte aggregation was increased in groups III and IV versus groups I and II. C3a was increased in group IV versus groups II and III. C5a and TxB did not vary between groups. PGI was greatly increased in group IV compared with groups I through III. C3a and C5a decreased in nonsurvivors. PaO2/FiO2 ratios correlated directly with PGI and inversely with C3a and TxB/PGI. Plasma PGI and C3a are increased in septic shock. C3a and TxB/PGI imbalances are involved in hypovolemic and septic shock.


Assuntos
Ativação do Complemento , Granulócitos/imunologia , Hipotensão/imunologia , Infecções/imunologia , Prostaglandinas/sangue , Adolescente , Adulto , Idoso , Agregação Celular , Complemento C3/análise , Complemento C3a , Complemento C5/análise , Complemento C5a , Epoprostenol/sangue , Feminino , Humanos , Hipotensão/sangue , Infecções/sangue , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Radioimunoensaio , Choque Séptico/sangue , Tromboxano B2/sangue
4.
Surgery ; 100(2): 214-21, 1986 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-3526603

RESUMO

Thromboxane A2 has been implicated as a mediator of cardiorespiratory dysfunction in sepsis. This study evaluated whether or not thromboxane A2 was necessary or sufficient for these adverse effects to occur during bacteremia. Fourteen adult swine under barbiturate anesthesia and breathing room air were monitored with arterial and pulmonary artery catheters. Animals were studied for 4 hours in three groups: group I, graded infusion of 10(9)/ml Aeromonas hydrophila; group II, Aeromonas hydrophila infusion plus SQ 29,548 (thromboxane A2 antagonist); and group III, U46619 (thromboxane A2 agonist) infusion in normal swine to pulmonary artery pressures observed in group I. Hemodynamic parameters, arterial and mixed venous blood gases, and plasma thromboxane B2 and prostaglandin 6-keto-F1 were measured. At sacrifice after 4 hours, wet-to-dry lung weights were calculated. Results indicated that thromboxane A2 was necessary and sufficient for the development of pulmonary hypertension and impaired alveolar-capillary oxygen diffusion in graded bacteremia. It was necessary but not sufficient for increased lung water to occur and sufficient but not necessary for decreased cardiac index and stroke volume index. Thromboxane A2 was neither sufficient nor necessary to the pathophysiology of systemic hypotension during graded bacteremia. Plasma prostaglandin 6-keto-F1 levels were increased in hypotensive animals with sepsis, suggesting its involvement in hypotension during sepsis.


Assuntos
Hemodinâmica , Hipertensão Pulmonar/fisiopatologia , Troca Gasosa Pulmonar , Sepse/fisiopatologia , Tromboxano A2/fisiologia , Ácido 15-Hidroxi-11 alfa,9 alfa-(epoximetano)prosta-5,13-dienoico , Aeromonas , Animais , Pressão Sanguínea , Compostos Bicíclicos Heterocíclicos com Pontes , Permeabilidade Capilar , Débito Cardíaco , Epoprostenol/sangue , Ácidos Graxos Insaturados , Hidrazinas/farmacologia , Hipóxia/fisiopatologia , Masculino , Endoperóxidos Sintéticos de Prostaglandinas/farmacologia , Choque Séptico/fisiopatologia , Suínos , Tromboxano A2/antagonistas & inibidores , Tromboxano B2/sangue
5.
Arch Surg ; 121(3): 305-7, 1986 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-3484946

RESUMO

Granulocyte aggregation (GA) response has previously been described as a sensitive assay for complement activation in sepsis. Complement component C5a has been implicated as the plasma factor responsible for GA. The quantitative interaction of complement components C3a and C5a with GA, however, is not clearly defined. This study evaluates the relationship of GA responses to plasma levels of C5a and C3a in zymosan-activated plasma (ZAP). The C3a and C5a levels were measured by radioimmunoassay in serial dilutions of ZAP. Granulocyte aggregation responses of normal human leukocytes were determined for each ZAP dilution. The C5a levels in a 1:16 dilution of ZAP were higher than in normal plasma (22 +/- 7 vs 9 +/- 3 ng/mL), as were GA responses (24 +/- 1 vs 11 +/- 2 percentage of maximum light transmission). The C3a levels in a 1:8 dilution of ZAP are elevated above those of normal plasma (656 +/- 167 vs 411 +/- 29 ng/mL). Correlation coefficients were .9809 for C3a vs GA, .9788 for C5a vs G, and .9860 for C3a vs C5a. Complement components C3a and C5a are involved in GA in vitro. Granulocyte aggregometry can detect low levels of activated complement in ZAP but may not be specific for C5a. The relative contribution of C3a and C5a to observed GA is not clear from the data.


Assuntos
Complemento C3/análise , Complemento C5/análise , Leucócitos/imunologia , Agregação Celular , Ativação do Complemento/efeitos dos fármacos , Complemento C3a , Complemento C5a , Estudos de Avaliação como Assunto , Humanos , Técnicas In Vitro , Métodos , Radioimunoensaio , Zimosan/farmacologia
6.
Arch Surg ; 121(3): 271-4, 1986 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-3511889

RESUMO

This study investigated the interaction of plasma levels of circulating prostaglandins and activated complement in clinical acute respiratory failure (ARDS). Fifty patients at risk for ARDS were followed up for up to ten days. Arterial blood gases and plasma levels of complement components C3a and C5a, thromboxane B2 (TxB), and prostaglandin 6-keto-F1 alpha (PGI) and granulocyte aggregation (GA) were measured daily. Seventeen patients (34%) developed ARDS, with mortality of 41% vs 23% for patients without ARDS. Compared with patients without ARDS, the ARDS group had significantly increased plasma C3a (1,130 +/- 750 vs 636 +/- 368 ng/mL) and granulocyte aggregation (48 +/- 10 vs 17 +/- 4 percentage of the maximum light transmission [% max T]). Plasma C5a, TxB, or PGI did not change significantly with or without ARDS. No measured variable was significantly associated with mortality. Regression analysis revealed significant correlations between GA, TxB, PGI, and arterial oxygenation. Plasma C3a and GA are increased in ARDS, suggesting systemic complement activation. A complex series of interactions between the prostaglandins, complement, and GA appears to be involved in ARDS.


Assuntos
Complemento C3/análise , Complemento C5/análise , Epoprostenol/sangue , Síndrome do Desconforto Respiratório/sangue , Tromboxano A2/sangue , Doença Aguda , Adolescente , Adulto , Idoso , Agregação Celular , Ativação do Complemento , Complemento C3a , Complemento C5a , Feminino , Granulócitos/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Oxigênio/sangue , Estudos Prospectivos , Radioimunoensaio , Análise de Regressão , Síndrome do Desconforto Respiratório/imunologia
7.
Am Surg ; 55(7): 413-6, 1989 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-2742224

RESUMO

The efficacy and associated morbidity and mortality of gastrostomy (G) versus nasogastric (NG) tube decompression after gastric surgery were analyzed in a review of 100 patients. Age, sex, and risk factors were homogeneously distributed between the two groups, while perforated ulcers and emergency operations were more common in the G group. A gastrostomy did not completely eliminate the need for NG tube decompression in the G group. Postoperative morbidity was similar in the two groups, with the exception of an increased incidence of atelectasis in the elective NG group and increased mortality in the emergency G group. There was also a significant increase in length and cost of hospitalization in the emergency G group compared with emergency NG patients. Gastrostomy does not appear to offer any significant advantage over nasogastric decompression after gastric surgery and should be limited to special cases.


Assuntos
Gastrostomia , Intubação Gastrointestinal , Estômago/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Avaliação como Assunto , Feminino , Gastrostomia/efeitos adversos , Gastrostomia/economia , Humanos , Intubação Gastrointestinal/efeitos adversos , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Úlcera Péptica Perfurada/complicações , Úlcera Péptica Perfurada/cirurgia , Cuidados Pós-Operatórios , Complicações Pós-Operatórias , Estudos Retrospectivos
8.
Otolaryngol Head Neck Surg ; 112(4): 544-8, 1995 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-7700660

RESUMO

Bone marrow transplantation for the treatment of leukemia is increasingly successful in rendering patients disease free. However, it has become evident that the associated severe immunosuppression predisposes this population to an increased risk for other neoplastic disorders. We report on six patients in whom non-Hodgkin's lymphoma of the tonsillar region developed within 5 months after T-cell-depleted bone marrow transplantation for the treatment of leukemia at Memorial Sloan-Kettering Cancer Center from October 1990 to October 1992. These patients initially had what appeared to be infectious exudative pharyngitis/tonsillitis; however, they did not improve with medical therapy. Because of the persistence of pharyngitis/tonsillitis in association with cervical lymphadenopathy and odynophagia, the patients underwent definitive biopsy in the form of tonsillectomy, cervical lymph node biopsy, or both. Histopathologic review revealed non-Hodgkin's lymphoma. An association with Epstein-Barr virus has been noted in five of these patients. This article is aimed at alerting the clinician to consider the diagnosis of lymphoma in a patient with persistent pharyngitis/tonsillitis despite adequate medical therapy after bone marrow transplantation.


Assuntos
Transplante de Medula Óssea/efeitos adversos , Herpesvirus Humano 4/isolamento & purificação , Leucemia Mieloide/terapia , Linfoma Difuso de Grandes Células B/diagnóstico , Linfoma Difuso de Grandes Células B/etiologia , Segunda Neoplasia Primária/diagnóstico , Neoplasias Tonsilares/diagnóstico , Neoplasias Tonsilares/etiologia , Tonsilite/etiologia , Adulto , Feminino , Humanos , Tolerância Imunológica , Leucemia Mielogênica Crônica BCR-ABL Positiva/terapia , Leucemia Mieloide Aguda/terapia , Linfoma Difuso de Grandes Células B/microbiologia , Masculino , Pessoa de Meia-Idade , Neoplasias Tonsilares/microbiologia , Tonsilite/microbiologia , Infecções Tumorais por Vírus/diagnóstico
9.
Ann Otol Rhinol Laryngol ; 105(7): 510-5, 1996 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8678425

RESUMO

The treatment of laryngeal and hypopharyngeal hemangiomas is indicated when they are symptomatic, causing dysphagia, recurrent bleeding, or airway obstruction. These tumors are found in the glottis, supraglottic larynx, and hypopharynx. Histologically, they are considered as mixed or cavernous-type hemangiomas. By utilizing a glass slide to compress the lesion, its thickness and blood flow are reduced. The tumor can then be laser-photocoagulated with less energy, with the glass slide used as a laser platform. These conditions optimize the benefits of laser ablation while minimizing the adverse heat sink effects to the surrounding healthy tissue. We present three patients with hemangiomas of the larynx and hypopharynx who were treated with this technique. The details of the technique in each case will be presented with the objective of improving the care of these unusual and challenging tumors.


Assuntos
Hemangioma/cirurgia , Neoplasias Hipofaríngeas/cirurgia , Hipofaringe/cirurgia , Neoplasias Laríngeas/cirurgia , Laringe/cirurgia , Terapia a Laser , Adulto , Feminino , Seguimentos , Hemangioma/patologia , Humanos , Neoplasias Hipofaríngeas/patologia , Hipofaringe/patologia , Neoplasias Laríngeas/patologia , Laringe/patologia , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA